Recently, Prausmüller et al. compared the performance of NT-ProBNP with the ESC/EASD risk model and the Systemic Coronary Risk Evaluation in predicting cardiovascular and all-cause mortality in 1690 unselected patients with type 2 diabetes [37]. This evidence concerns the gene NPPB and type 2 diabetes mellitus.